Skip to main content
Signal8
Poetting Sierk profile photo

Sierk Poetting

CIK: 0001955589

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BioNTech SE logo
BNTX

BioNTech SE

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • BioNTech SE logo
    BNTX

    BioNTech SE

    May 12, 2026
    Award(A)

    Option (right to buy)

    Direct
    12.6K shares-
  • BioNTech SE logo
    BNTX

    BioNTech SE

    May 12, 2026
    Award(A)

    Performance Share Unit

    Direct
    10.1K shares-
  • BioNTech SE logo
    BNTX

    BioNTech SE

    Apr 22, 2026
    Sale(S)
    Indirect
    50K shares at avg. $110.56$5.5M

1-3 of 3

About Poetting Sierk

Poetting Sierk (SEC CIK 0001955589) files insider reports with the SEC as Chief Operating Officer of BioNTech SE (BNTX).

Signal8 holds 3 ownership filings by Poetting Sierk (1 Form 3, 2 Form 4), filed between Mar 18, 2026 and May 13, 2026. Those filings report 3 transactions, from Apr 22, 2026 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Poetting Sierk's filings is in MAINZ.

Recent filings by Poetting Sierk

  • May 12, 2026: Grants or awards of BNTX derivative securities (2 lines, Form 4, code A).
  • Apr 22, 2026: Open-market sale of BNTX shares (Form 4, code S).

Other insiders filing for BioNTech SE (BNTX)

How to read Form 4 transaction codes